A High-throughput Assay to Assess and Quantify Neutrophil Extracellular Trap Formation
January 29th, 2019
12.6K views
This protocol describes a highly sensitive and high throughput neutrophil extracellular trap (NET) assay for the semi-automated quantification of ex vivo NET formation by immunofluorescence three-dimensional confocal microscopy. This protocol can be used to evaluate NET formation and degradation after different stimuli and can be used to study potential NET-targeted therapies.
Overview
This protocol describes a high-throughput assay for quantifying neutrophil extracellular traps (NETs) using three-dimensional immunofluorescence confocal microscopy. It enables the evaluation of NET formation and degradation in response to various stimuli, facilitating the study of NET-targeted therapies.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Autoimmunity
Background
- Neutrophil extracellular traps (NETs) are DNA structures released by neutrophils.
- NETs play a crucial role in trapping and killing pathogens.
- They are also implicated in the pathogenesis of autoimmune diseases.
- Quantifying NET formation can provide insights into disease mechanisms and potential therapies.
Purpose of Study
- To develop a sensitive assay for measuring NET formation.
- To evaluate NET responses to different stimuli.
- To assess potential therapeutic interventions targeting NETs.
Methods Used
- Isolation of neutrophils from peripheral blood.
- Labeling neutrophils with a red fluorescent cell linker.
- Incubation with various stimuli and impermeable DNA dye.
- Quantification of NETs using confocal microscopy.
Main Results
- The assay allows for high-throughput quantification of NET formation.
- NET formation can be monitored in patients with autoimmune diseases.
- The method is sensitive and suitable for testing potential NET-targeted therapies.
- Results can inform the understanding of NET-related pathologies.
Conclusions
- This protocol provides a reliable method for studying NETs.
- It can be applied to various research contexts, including autoimmune disease studies.
- The assay has potential for evaluating therapeutic strategies targeting NETs.
Frequently Asked Questions
What are neutrophil extracellular traps (NETs)?
NETs are web-like structures composed of DNA and proteins released by neutrophils to trap and kill pathogens.
How does the assay quantify NET formation?
The assay uses three-dimensional immunofluorescence confocal microscopy to visualize and quantify NETs.
What stimuli can be used in this assay?
Various stimuli can be tested to induce NET formation, including pathogens and inflammatory signals.
Can this assay be used for patient samples?
Yes, the assay is designed to quantify NET formation in patient samples, particularly those with autoimmune diseases.
What is the significance of studying NETs?
Studying NETs helps understand their role in immune responses and their involvement in autoimmune diseases.
Is the method suitable for high-throughput screening?
Yes, the assay is optimized for high-throughput analysis, allowing for the testing of multiple conditions simultaneously.
Executive Industry Relevance
This high-throughput assay enables quantitative assessment of neutrophil extracellular trap (NET) formation, a key mechanism in autoimmune pathogenesis. By providing sensitive, reproducible measurement of NETs in patient samples, it supports target validation and mechanistic de-risking in immunology-focused drug discovery. The method facilitates evaluation of NET-modulating therapeutics, informing go/no-go decisions in preclinical pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of NET formation as a therapeutic target in autoimmune diseases like AAV and SLE.
- Operational Value: Provides quantitative, imaging-based readout for assessing target engagement of NET-modulating compounds.
- Predictive Value: Supports biomarker-aligned hypothesis testing to de-risk mechanistic assumptions in early discovery.
Screening & Assay Development
- Scientific Value: Generates standardized, high-content data on NET formation across stimuli and inhibitor conditions.
- Operational Value: Compatible with 96-well plate formats, enabling scalable screening of compound libraries.
- Assay Readiness: Produces objective, confocal microscopy-derived metrics suitable for assay optimization and Z'-factor determination.
Translational & Preclinical Research
- Scientific Value: Measures ex vivo NET formation from patient neutrophils, linking in vitro findings to disease-relevant biology.
- Operational Value: Enables longitudinal monitoring of NET responses in autoimmune patient cohorts.
- Translational Continuity: Supports evaluation of NET-targeted therapies using clinically relevant primary cells.
Pipeline & Workflow Integration
The assay fits within the immunology discovery continuum, from target validation through lead optimization to preclinical efficacy testing, by delivering quantitative NET formation data that informs compound progression.
- Discovery Biology: Supports hypothesis-driven interrogation of NETosis pathways and stimulus-specific NET formation mechanisms.
- Screening: Enables reproducible, high-throughput quantification of NETs in response to compound libraries or cytokine panels.
- Analytics: Delivers cumulative extracellular DNA area per neutrophil as a quantitative, normalized readout for dose-response analysis.
- Translational Research: Uses primary neutrophils from healthy donors and autoimmune patients to assess disease-specific NET phenotypes.
- Enterprise Reuse: Establishes a standardized, confocal microscopy-based platform applicable across multiple immunology projects.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in NET-targeted hypotheses through quantitative, imaging-based validation.
- Operational Value: Enhances reproducibility and standardization of NET assessment across laboratories and sites.
- Strategic Value: Improves go/no-go decision-making by reducing biological uncertainty in NET-modulating therapeutic strategies.
- Portfolio Impact: Enables risk-adjusted prioritization of NET inhibitors based on mechanistic and phenotypic efficacy data.
Implementation Considerations
- Requires expertise in neutrophil isolation, fluorescent labeling, and confocal microscopy operation.
- Dependent on access to immunofluorescence confocal microscopy with Z-stack acquisition and analysis software.
- Necessitates standardization of staining protocols and imaging parameters across users and experiments.
- Involves optimization considerations for stimulus concentration, incubation time, and neutrophil density across model systems.
- Limited by the technical complexity of neutrophil handling and the need for aseptic, timed procedures to maintain cell viability and function.
Biopharma FAQs
Why does quantifying NET formation matter for target validation in autoimmune disease?
Quantifying NET formation provides a direct, measurable readout of target engagement in pathways implicated in AAV and SLE. This enables objective assessment of whether a compound modulates NETosis, supporting mechanistic validation of immunology targets. The assay’s sensitivity and reproducibility increase confidence in target hypothesis during early discovery.
How does isolating neutrophils as an independent variable support discovery pipeline integrity?
Isolating neutrophils from peripheral blood ensures that observed NET formation is attributable to the cellular response rather than confounding plasma factors. This isolation enables consistent, reproducible testing of stimuli or compounds on a defined cellular system. By controlling this variable, researchers can attribute changes in NET formation specifically to experimental conditions.
What do quantitative measurements of extracellular DNA area enable in NET analysis?
Measuring cumulative stained extracellular DNA area over Z-stacks provides a normalized, quantitative readout of NET formation per neutrophil. This metric correlates strongly with total neutrophil count, allowing for accurate comparison across wells and conditions. The quantitative output supports dose-response modeling and statistical analysis of compound effects.
Why are replication requirements important for cross-functional collaboration in NET assay use?
Running stimuli and controls in triplicate ensures data reliability and enables statistical validation of NET formation differences. Replication supports assay robustness, which is essential when sharing results across discovery, preclinical, and translational teams. Consistent replication practices build confidence in data used for go/no-go decisions.
What statistical analysis capabilities are required before implementing this NET quantification assay?
Implementation requires the ability to analyze variance across replicates, calculate correlation coefficients (e.g., Pearson’s r for neutrophil count vs. imaged area), and generate dose-response curves. The assay outputs spreadsheet-compatible data suitable for t-tests, ANOVA, or EC50 determination. These capabilities are necessary to interpret NET formation data in a statistically rigorous, decision-supporting context.
Chapters in this video
0:04
Title
1:13
Isolation of Healthy Neutrophils
3:42
Red Fluorescent Cell Labelling of Neutrophils
5:10
Induction of Neutrophil Extracellular Trap Formation
6:42
NET Visualization with 3D High-content, High-resolution Immunofluorescence Confocal Microscopy and Analysis of NET Formation
7:59
Results: Assessment and Quantification of Neutrophil Extracellular Trap Formation
9:26
Conclusion
